Sleek Pharmaceuticals Private Limited
About Sleek Pharmaceuticals Private Limited
Data last updated:
Sleek Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the general construction services segment of the infrastructure and utilities sector. It was incorporated on 01 July 1997 and has been in existence for over 29 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL1997PTC088270. Its GSTIN is 09AACCS9303H1ZA (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5.07 Lakh. It is led by directors including Ravinder Kumar and Jai Lal Deep.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 10/B D.L.F Galaria Mall G.F. Mayur Vihar, New Delhi, Delhi, India – 110091.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.18 Cr, a growth of 2% compared to the previous year. For the same year it recorded a net profit of ₹21.7 Lakh (net margin 18.4%) and EBITDA of ₹37.77 Lakh (EBITDA margin 32%). Revenue has declined at a compounded annual rate (CAGR) of 3% over three years and 5% over five years.
The company has about 4 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹60 Lakh on record. Court records list 2 cases involving the company, including 2 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Sleek Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address10/B D.L.F Galaria Mall G.F. Mayur Vihar, New Delhi, Delhi, India – 110091
- IndustryInfrastructure and Utilities, General Construction Services
To see the full contact details of Sleek Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sleek Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Sleek Pharmaceuticals Private Limited, buy the company report.
Financials of Sleek Pharmaceuticals Private Limited
FY 2025 filings availableSleek Pharmaceuticals Private Limited reported revenue of ₹1.18 Cr (up 2% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 2% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 5%. EBITDA fell 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹37.77 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹21.7 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 32% | ||||
| Net Profit Margin | 18.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sleek Pharmaceuticals Private Limited, buy the company report.
Board of directors of Sleek Pharmaceuticals Private Limited
Sleek Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ravinder Kumar | Director | 01 Jul 1997 | 29 Years 4 Months | Current |
| Jai Lal Deep Also directs: Shivalik Medicare Private Limited, Sleek Marketing Private Limited, Anant Sales Private Limited and 2 more | Director | 01 Jul 1997 | 29 Years 4 Months | Current |
| Adip Kumar Also directs: Shivalik Medicare Private Limited, Sleek Marketing Private Limited, K&A Apparel Innovations LLP and 3 more | Director | 01 Jul 1997 | 29 Years 4 Months | Current |
Auditor
Sleek Pharmaceuticals Private Limited is audited by RISHI KAPOOR AND COMPANY for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RISHI KAPOOR AND COMPANY | FY 2022 | 006615C |
Shareholding
The shareholding of Sleek Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sleek Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 06 May 2008 | 10103201 | Pnb Housing Finance Limited | ₹60 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Sleek Pharmaceuticals Private Limited has 2 court cases on record: 2 filed against it. 1 case is pending and 1 is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 1 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ghaziabad, Uttar Pradesh | Criminal case | Filed against the company by State Government | Pending |
| District court, Ghaziabad, Uttar Pradesh | Criminal case | Filed against the company by State Government | Disposed |
To see the full case history of Sleek Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sleek Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Sleek Pharmaceuticals Private Limited has a workforce of 4 employees on its EPFO records as of Oct 10, 2025, across 1 active EPFO establishment.
GST
Sleek Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AACCS9303H1ZA | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sleek Pharmaceuticals Private Limited, buy the company report.
Recent activity
Sleek Pharmaceuticals Private Limited has 3 board changes on record since 1997: 3 appointments. The latest: Adip Kumar was appointed as Director on 01 Jul 1997.
Frequently asked questions
Sleek Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in general construction services, within the infrastructure and utilities industry. It was incorporated on 01 July 1997 (29+ years old) and is registered under CIN U24232DL1997PTC088270.
Sleek Pharmaceuticals has 3 current directors:
- Ravinder Kumar - Director
- Jai Lal Deep - Director
- Adip Kumar - Director
The latest financial statements of Sleek Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Sleek Pharmaceuticals is 09AACCS9303H1ZA, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Sleek Pharmaceuticals is U24232DL1997PTC088270. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sleek Pharmaceuticals has 2 court cases on record: 2 filed against it. 1 is pending.
Sleek Pharmaceuticals was incorporated on 01 July 1997, making it 29+ years old. It is registered with the Registrar of Companies, Delhi.
Adip Kumar was appointed as Director on 01 Jul 1997. Jai Lal Deep was appointed as Director on 01 Jul 1997. Ravinder Kumar was appointed as Director on 01 Jul 1997.
The registered office of Sleek Pharmaceuticals is at 10B D.L.F Galaria Mall G.F. Mayur Vihar, New Delhi, Delhi, India – 110091.
Sleek Pharmaceuticals operates in the infrastructure and utilities industry, in the general construction services segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
